Soleno Therapeutics
Stock Forecast, Prediction & Price Target
Soleno Therapeutics (SLNO) stock Price Target by analysts
$72
Potential upside: 7.76%
Soleno Therapeutics price prediction
What is Soleno Therapeutics stock analysts` prediction?
Soleno Therapeutics stock forecast: Based on 2 Wall Street analysts` predicted price targets for Soleno Therapeutics in the last 3 months, the avarage price target is $72, with a high forecast of $NaN. The average price target represents a 7.76% change from the last price of $66.81.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Soleno Therapeutics stock Price Target by analysts
Full breakdown of analysts given Soleno Therapeutics price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Raghuram Selvaraju H.C. Wainwright | 0% 0/1 | 10 months ago | $70 4.77% upside | $50.91 | StreetInsider | Previous targets (0) |
Dae Gon Ha Stifel Nicolaus | 0% 0/1 | 12 months ago | $74 10.76% upside | $50.49 | TheFly | Previous targets (0) |
Leland Gershell Oppenheimer | 0% 0/1 | about 1 year ago | $65 -2.70% downside | $46.76 | StreetInsider | Previous targets (0) |
Dae Gon Stifel Nicolaus | 0% 0/1 | about 1 year ago | $59 -11.68% downside | $49.04 | StreetInsider | Previous targets (0) |
Yasmeen Rahimi Piper Sandler | 0% 0/1 | over 1 year ago | $93 39.20% upside | $42.42 | StreetInsider | Previous targets (0) |
Brian Skorney Robert W. Baird | 0% 0/1 | over 1 year ago | $72 7.76% upside | $47.64 | StreetInsider | Previous targets (0) |
Soleno Therapeutics Financial Estimates
Soleno Therapeutics Revenue Estimates
Soleno Therapeutics EBITDA Estimates
Soleno Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $44.75M Low: $26.28M High: $55.57M avg. 0% | Avg: $160.90M Low: $78.14M High: $262.65M avg. 259.55% | Avg: $314.81M Low: $152.89M High: $513.90M avg. 95.65% | Avg: $479.57M Low: $232.91M High: $782.85M avg. 52.33% |
Net Income
% change YoY
| $-29.56M N/A | $-20.31M 31.26% | $-38.98M -91.87% | Avg: $-78.55M Low: $-46.50M High: $-9.23M avg. -101.48% | Avg: $10.83K Low: $-41.23M High: $32.98M avg. 100.01% | Avg: $54.71M Low: $18.12M High: $99.69M avg. 505095.30% | Avg: $102.29M Low: $33.89M High: $186.38M avg. 86.96% |
EBITDA
% change YoY
| $-31.53M N/A | $-25.85M 18.02% | $-37.03M -43.24% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$5.56 N/A | -$2.42 56.47% | -$2.36 2.47% | Avg: -$1.8 Low: -$2.82 High: -$0.56 avg. 23.66% | Avg: $0.49 Low: -$2.5 High: $2 avg. 126.92% | Avg: $3.32 Low: $1.1 High: $6.04 avg. 584.02% | Avg: $6.2 Low: $2.06 High: $11.3 avg. 86.96% |
Operating Expenses
% change YoY
| $32.25M N/A | $25.10M -22.16% | $41.38M 64.81% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Soleno Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 126295.19% in 2025-2028.
We have gathered data from 5 analysts. Their low estimate is -46.50M, average is -78.55M and high is -9.23M.
What is Soleno Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 101.88% in 2025-2028.
We have gathered data from 5 analysts. Their low revenue estimate is $26.28M, average is $44.75M and high is $55.57M.
What is Soleno Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 205.39% in 2025-2028.
We have gathered data from 5 analysts. Their low earnings per share estimate is -$2.82, average is -$1.8 and high is $-0.56.
What is the best performing analyst?
In the last twelve months 2 analysts have been covering Soleno Therapeutics stock. The most successful analyst is Raghuram Selvaraju.